Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 16;65(8):e0033021.
doi: 10.1128/AAC.00330-21. Epub 2021 Jul 16.

MAB_2355c Confers Macrolide Resistance in Mycobacterium abscessus by Ribosome Protection

Affiliations

MAB_2355c Confers Macrolide Resistance in Mycobacterium abscessus by Ribosome Protection

Qi Guo et al. Antimicrob Agents Chemother. .

Abstract

Macrolide resistance is always a concern when treating Mycobacterium abscessus infections. MAB_2355c was identified previously as a possible new factor that confers the intrinsic resistance of 194 clinical M. abscessus isolates to clarithromycin. Herein, the potential mechanism by which MAB_2355c exerts macrolide resistance was explored by bioinformatics analysis, MAB_2355c cloning and protein purification, ATP hydrolysis assay, gene knockout and complementation, antibiotic sensitivity, and transcription-translation assays. MAB_2355c is a putative ATP-binding cassette F (ABC-F) family protein. Purified MAB_2355c protein exhibits ATP hydrolysis activity, which can be inhibited by ribosome-targeting antibiotics. MAB_2355c mRNA expression is upregulated more significantly after exposure to macrolides than after exposure to other ribosome-targeting antibiotics. MAB_2355c deleted strains showed increased sensitivity to macrolides, which was reduced by MAB_2355c complementation. Finally, MAB_2355c rescued the transcription and translation activities affected by macrolides in vitro. These findings suggest that MAB_2355c confers the resistance of M. abscessus to macrolides by ribosome protection, thus complementing other known resistance mechanisms.

Keywords: ABC-F protein; MAB_2355c; Mycobacterium abscessus; macrolides; resistance; ribosome.

PubMed Disclaimer

Figures

FIG 1
FIG 1
MAB_2355c exhibits similarities to ABC-F subfamily proteins. (A) Schematic diagram of the conserved domains of MAB_2355c predicted by the Pfam database. ABC_tran (PF00005) and ABC_tran_Xtn (PtIM, PF12848) were found in MAB_2355c. (B) The amino acid sequences of the ABC-F subfamily proteins were aligned and shaded using DNAMAN software. Dark blue represents 100% homology, and light blue represents 75% homology. The amino acid sequences used for alignment include MAB_2355c (GenBank accession numbers CAM62436), Rv2477c (CCP45271), MsrA (ADM29228), and EttA (P0A9W3). The annotation above the MAB_2355c sequence indicates the following conserved motifs: Walker A, ABC signature, Walker B.
FIG 2
FIG 2
Characterization of purified MAB_2355c ATPase activity and changes in MAB_2355c expression after exposure to ribosome-targeting antibiotics. (A) Coomassie-stained SDS-PAGE confirmed the accuracy of MAB_2355c induction and purification. MW, molecular weight marker. Lane 1, before IPTG induction; lane 2, after IPTG induction; and lane 3, purified MAB_2355c protein. (B) The MAB_2355c protein exhibits ATP, TTP, CTP, and GTP hydrolase activity. (C) MAB_2355c protein (1 μM) was preincubated with 1 mM antibiotic for 15 min at room temperature prior to the addition of ATP. ATP hydrolysis was quantified after deducting the background (solvent rather than antibiotic added). Data in panels C and D represent the mean ± standard deviation (SD), and statistical significance was analyzed by one-tailed t test versus buffer controls. *, P < 0.05; **, P < 0.01; ***, P < 0.001. (D) Fold MAB_2355c transcript induction in wild-type M. abscessus ATCC 19977 after 30 min and 3 h exposure to 0.5 MIC ribosome-targeting antibiotics. The results are expressed as fold increased expression compared to unexposed samples. Data represent the mean ± SD, sigA was used as an endogenous reference gene. All experiments were repeated independently three times.
FIG 3
FIG 3
Construction of knockout and complementation strains. (A) Schematic representation of the MAB_2355c deletion created using phage recombineering. (B) Using LYZFP/LYZRP and RYZFP/RYZRP primer pairs, 1,270 bp LYZ and 1,292 bp RYZ were amplified, respectively, confirming MAB_2355c deletion; the knockout strain (MUT) was used as a template. No targeted DNA fragment was amplified using the wild-type strain (WT) as a template. (C) Three complementation clones were randomly selected (numbers 1 to 3), and the JDP DNA fragment was amplified using the JDLP and JDRP primers and confirmed by sequencing.
FIG 4
FIG 4
MAB_2355c deletion renders M. abscessus sensitive to macrolides. Ten-fold dilutions of ATCC 19977 wild-type, ATCC 19977ΔMAB_2355c mutant, and ATCC 19977ΔMAB_2355c:pMV361_MAB_2355c complementation strains were spotted onto Middlebrook 7H10 agar plates containing the indicated antibiotic concentrations. MAB_2355c deletion rendered M. abscessus ATCC 19977 more sensitive than the wild-type parental strain to erythromycin, azithromycin, clarithromycin, and linezolid. An integrated, constitutively expressed copy of MAB_2355c in the complementation strain partially restored antibiotic resistance.
FIG 5
FIG 5
MAB_2355c rescues in vitro transcription-translation from erythromycin inhibition in a dose-dependent manner. (A) Erythromycin inhibitory activity profile in an in vitro coupled transcription-translation luciferase assay. (B) Transcription-translation activity in the absence of erythromycin and MAB_2355c (column 1) or the presence of 3 μM erythromycin (E) and increasing concentrations of MAB_2355c protein (columns 2 to 5). Results are the means ± SD of data from three independent experiments.

Similar articles

Cited by

References

    1. Johansen MD, Herrmann JL, Kremer L. 2020. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat Rev Microbiol 18:392–407. 10.1038/s41579-020-0331-1. - DOI - PubMed
    1. Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B. 2012. Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother 67:810–818. 10.1093/jac/dkr578. - DOI - PubMed
    1. Medjahed H, Gaillard JL, Reyrat JM. 2010. Mycobacterium abscessus: a new player in the mycobacterial field. Trends Microbiol 18:117–123. 10.1016/j.tim.2009.12.007. - DOI - PubMed
    1. Jeong YJ, Lee KS, Koh WJ, Han J, Kim TS, Kwon OJ. 2004. Nontuberculous mycobacterial pulmonary infection in immunocompetent patients: comparison of thin-section CT and histopathologic findings. Radiology 231:880–886. 10.1148/radiol.2313030833. - DOI - PubMed
    1. Yu X, Liu P, Liu G, Zhao L, Hu Y, Wei G, Luo J, Huang H. 2016. The prevalence of non-tuberculous mycobacterial infections in mainland China: systematic review and meta-analysis. J Infect 73:558–567. 10.1016/j.jinf.2016.08.020. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources